Navigator Global Investments Ltd – Transaction Update on Mesirow’s Asset

investment

Navigator Global Investments Limited (ASX: NGI) disclosed an update on acquisition of Mesirow Advanced Strategies’ assets wherein the group has completed its acquisition of all the assets of Mesirow Advanced Strategies on July 01, 2018. The consideration for the transaction is deferred and wholly contingent in nature. As a component of the procedure for determining the fair value of the acquired assets, the group is in the process of estimating the future contingent consideration to be paid in relation to the transaction. This contingent consideration will be paid in the future as calculated under an earnout payment over the seven years, estimated as an agreed percentage of EBITDA generated by the transitioned assets above a floor amount.

Based on current assumptions, the management assumes that the future contingent consideration payment will be around US$ 10 Mn over the 7-year period.

Further, the group will provide additional information in relation to the future accounting impacts of the transaction during the announcement of 2018 full-year results. Though, it is expected that consideration payment will be funded from future operating cash flows.

With this update, the share price zoomed up 6.3% on July 20, 2018 with the market capitalization of $895.06 Mn before market close.

[pluginops_form template_id=’23834′ ]

 

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report